446 related articles for article (PubMed ID: 12489493)
21. Alkaline phosphatase activity in neutrophils from patients with severe congenital neutropenia (Kostmann's syndrome).
Baranova K; Stanulla M; Zeidler C; Welte K
Int J Hematol; 1999 Dec; 70(4):236-40. PubMed ID: 10643149
[TBL] [Abstract][Full Text] [Related]
22. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.
Rosenberg PS; Alter BP; Bolyard AA; Bonilla MA; Boxer LA; Cham B; Fier C; Freedman M; Kannourakis G; Kinsey S; Schwinzer B; Zeidler C; Welte K; Dale DC;
Blood; 2006 Jun; 107(12):4628-35. PubMed ID: 16497969
[TBL] [Abstract][Full Text] [Related]
23. [Chronic congenital neutropenia treated with granulocyte colony-stimulating factor (G-CSF)].
Jonsbo F
Ugeskr Laeger; 1992 Feb; 154(8):492-3. PubMed ID: 1371630
[TBL] [Abstract][Full Text] [Related]
24. Chromosomal aberrations in congenital bone marrow failure disorders--an early indicator for leukemogenesis?
Göhring G; Karow A; Steinemann D; Wilkens L; Lichter P; Zeidler C; Niemeyer C; Welte K; Schlegelberger B
Ann Hematol; 2007 Oct; 86(10):733-9. PubMed ID: 17653548
[TBL] [Abstract][Full Text] [Related]
25. Severe chronic neutropenia: pathophysiology and therapy.
Welte K; Boxer LA
Semin Hematol; 1997 Oct; 34(4):267-78. PubMed ID: 9347577
[TBL] [Abstract][Full Text] [Related]
26. Hematopoietic growth factors in the treatment of acquired bone marrow failure states.
Marsh JC; Ganser A; Stadler M
Semin Hematol; 2007 Jul; 44(3):138-47. PubMed ID: 17631178
[TBL] [Abstract][Full Text] [Related]
27. [Indications of G-CSF administration in hematologic disorders].
Lionne-Huyghe P; Kuhnowski F; Coiteux V; Bauters F; Morschhauser F
Bull Cancer; 2006 May; 93(5):453-62. PubMed ID: 16777623
[TBL] [Abstract][Full Text] [Related]
28. Chronic idiopathic neutropenias and severe congenital neutropenia.
Palmblad J; Papadaki HA
Curr Opin Hematol; 2008 Jan; 15(1):8-14. PubMed ID: 18043240
[TBL] [Abstract][Full Text] [Related]
29. Two patients with nonimmune chronic idiopathic neutropenia of adults developing acute myeloid leukemia with aberrant phenotype and complex karyotype but no mutations in granulocyte colony-stimulating factor receptor.
Papadaki HA; Kosteas T; Gemetzi C; Alexandrakis M; Psyllaki M; Eliopoulos GD
Ann Hematol; 2002 Jan; 81(1):50-4. PubMed ID: 11807637
[TBL] [Abstract][Full Text] [Related]
30. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
[TBL] [Abstract][Full Text] [Related]
31. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
[TBL] [Abstract][Full Text] [Related]
32. Kostmann's syndrome with chronic pneumonia and lymphocytosis: effect of recombinant human G-CSF.
Yetgin S; Ozbek N; Tuncer M; Göçmen A; Ozçelik U
Turk J Pediatr; 1994; 36(1):87-91. PubMed ID: 7514821
[TBL] [Abstract][Full Text] [Related]
33. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
34. [Hypoplastic myelodysplastic syndrome progressing to acute myelocytic leukemia (M2) after treatment with G-CSF and immunosuppressants].
Miyata A; Deguchi S; Kikuchi T; Osada T; Sanada H
Rinsho Ketsueki; 1998 Jun; 39(6):453-9. PubMed ID: 9695675
[TBL] [Abstract][Full Text] [Related]
35. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
[TBL] [Abstract][Full Text] [Related]
36. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
Ghalaut PS; Sen R; Dixit G
J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
[TBL] [Abstract][Full Text] [Related]
37. Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia.
McLemore ML; Poursine-Laurent J; Link DC
J Clin Invest; 1998 Aug; 102(3):483-92. PubMed ID: 9691084
[TBL] [Abstract][Full Text] [Related]
38. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF].
Borota R; Borota J; Belić A; Gebauer E; Stefanović N
Med Pregl; 1997; 50(3-4):87-93. PubMed ID: 9229690
[TBL] [Abstract][Full Text] [Related]
39. Potential clinical applications of rhGM-CSF in acute myeloid leukemia based on its biologic activity and receptor interaction.
Lanza F; Rigolin GM; Castagnari B; Moretti S; Castoldi G
Haematologica; 1997; 82(2):239-45. PubMed ID: 9175331
[TBL] [Abstract][Full Text] [Related]
40. Kostmann's syndrome.
Joazlina ZY; Wastie ML; Kamarulzaman A
Clin Imaging; 2005; 29(5):364-6. PubMed ID: 16153548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
